Mirion Technologies, Inc.
Financials
Valuation Metrics
Mirion Technologies, Inc.'s Market Cap is $4.57B. At end of 2025 it was $5.72B. Ranked #1569 of 3,114 in US market (top 50%), #1024 of 1,645 on NYSE (top 62%), #152 of 240 in Capital Goods (top 63%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.57B | US#1,569/3,114 Sec#152/240 |
| Revenue | $1.08B | US#1,852/3,114 Sec#180/240 |
| Net Income | $29M | US#2,061/3,114 Sec#180/240 |
| Total Assets | $3.50B | US#1,693/3,114 Sec#132/240 |
| Net Assets | $1.79B | US#1,305/3,114 Sec#110/240 |
| Employees | 3,281 | US#1,436/3,114 Sec#164/240 |
| Value | ||
| P/E | 157.55x | US#2,154/3,114 Sec#189/240 |
| P/B | 2.56x | US#1,274/3,114 Sec#59/240 |
| PEG | 16.70x | US#837/3,114 Sec#69/240 |
| P/S | 4.23x | US#1,943/3,114 Sec#171/240 |
| EV/EBITDA | 23.73x | US#1,927/3,114 Sec#148/240 |
| FCF Yield | 3.74% | US#1,662/3,114 Sec#120/240 |
| Profitability | ||
| ROE | 1.62% | US#2,063/3,114 Sec#189/240 |
| ROA | 0.83% | US#2,087/3,114 Sec#192/240 |
| Op. Margin | 5.96% | US#1,934/3,114 Sec#171/240 |
| Revenue Growth | 19.65% | US#862/3,114 Sec#80/240 |
| Earnings Growth | 9.43% | US#211/3,114 Sec#14/240 |
| Financial Health | ||
| Debt Ratio | 93.24% | US#983/3,114 Sec#79/240 |
| Total Debt | $1.24B | US#1,420/3,114 Sec#104/240 |
| FCF | $171M | US#1,587/3,114 Sec#137/240 |
| Cash | $409M | US#1,182/3,114 Sec#86/240 |
| Current Ratio | 3.02x | US#729/3,114 Sec#43/240 |
| Net Debt/EBITDA | 3.66x | US#1,796/3,114 Sec#175/240 |
| Performance | ||
| 1Y Return | -36.41% | US#2,694/3,114 Sec#208/240 |
| 1M Return | 27.91% | US#2,277/3,114 Sec#155/240 |
| From 52W High | -35.18% | US#2,649/3,114 Sec#195/240 |
| 1Y MDD | -50.54% | US#2,490/3,114 Sec#193/240 |
| Trading | ||
| Volume | 4,097,844 shares | US#859/3,114 Sec#54/240 |
| Trading Value | $77M | US#1,575/3,114 Sec#151/240 |
| Per Share | ||
| EPS | $0.12 | US#2,080/3,114 Sec#191/240 |
| BPS | $7.30 | US#2,040/3,114 Sec#192/240 |
Company Info
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.